Forward and Backward Walking Exercise on Physical and Cognitive Functions

September 19, 2024 updated by: Hilal Denizoğlu Külli, Atlas University

Acute Effect of Forward and Backward Walking Exercise on Physical and Cognitive Functions

To investigate the acute effects of forward and backward walking exercise on physical functions such as static and dynamic balance and cognitive functions such as attention, concentration, memory, processing speed, visual structuring skills, calculation and orientation.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study is planned to investigate the acute effects of forward and backward walking on physical functions such as static and dynamic balance and cognitive functions such as attention, concentration, memory, processing speed, visual structuring skills, calculation and orientation. 50 healthy individuals were randomly divided into three groups for the study. The groups were divided into Backward Walking Exercise Group (GYE) (n=17), Forward Walking Exercise Group (FWE) (n=16) and Control Group (CG)(n=17). Before treatment for all three groups; sociodemographic and clinical data with the sociodemographic information form, physical activity levels with the International Physical Activity Survey Short Form, pain severity with the Visual Analog Scale (VAS), fatigue levels with the Borg Scale, the person's selective attention capacity and skills, processing speed and general executive processing abilities. Stroop Test with TBAG Form to evaluate executive functions such as working memory, complex attention, planning and set shifting, with Trail Making Test, evaluation of dynamic balance, neuromuscular control and movement asymmetries with Y-Balance Test, static balance, postural stability evaluation on One Leg It was evaluated with the Standing Test. The GYE group completed a 25-minute backward walking exercise session, the FWE group completed a 25-minute forward walking exercise session, and the control group completed a 30-minute sitting rest between evaluation tests. After the exercises, there were significant differences in parameters such as attention, processing speed, concentration and maintenance of attention, working memory, planning, static and dynamic balance, and in the comparison between groups, significant differences were found in static balance and postural control (p<0.05). It was observed that individuals in the backward walking group showed better improvements in some parameters after walking. However, these results need to be supported by future studies.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Kagıthane
      • Istanbul, Kagıthane, Turkey
        • Istanbul Atlas University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy university students aged 18-25 years were included in the study, excluding physically active individuals according to the International Physical Activity Scale Short Form.

Description

Inclusion Criteria:

  • To be between the ages of 18-25,
  • To be able to communicate verbally and in written Turkish,
  • Not complaining of pain in any part of the body during physical activity,
  • Performing a normal walking pattern without compensatory movements.

Exclusion Criteria:

  • Participants participating in a routine exercise program
  • History of upper or lower extremity pathology or injury in the last 6 months
  • Diagnosed neurological disease
  • Diagnosed cognitive impairment
  • Having a diagnosed orthopedic disease
  • Using a walking aid
  • Inadequate cardiovascular fitness
  • Dyspnea on exertion
  • Contraindication to walking
  • Receiving medical treatment that causes imbalance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Backward walking exercise group
Healthy subjects aged 18-25 years were included in the study. Cognitive and physical function assessments were performed face-to-face by a physiotherapist before and after backward walking exercise. In addition, assessments during the exercise were performed by the same physiotherapist. Assessments were made immediately before and immediately after the walking exercise. All assessments were supervised by the physiotherapist.
Other: Backward walking
The exercises consisted of a 5-minute warm-up on a treadmill followed by a 25-minute period of moderate backward walking.
Forward walking exercise group
Healthy subjects aged 18-25 years were included in the study. Cognitive and physical function assessments were performed face-to-face by a physiotherapist before and after forward walking exercise. In addition, assessments during the exercise were performed by the same physiotherapist. Assessments were made immediately before and immediately after the walking exercise. All assessments were supervised by the physiotherapist.
Other: Forward walking
The exercises consisted of a 5-minute warm-up on a treadmill followed by a 25-minute period of moderate forward walking.
Control group
Participants did not perform any walking exercise. Cognitive and physical function assessments were performed before and after the assessment tests, with 30 minutes of rest in between.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Stroop Test TBAG Form
Time Frame: immediately pre and immediately post-exercise
Stroop Test TBAG Form was used to assess executive functions such as attention, memory, concentration, visual structuring skills, computational working memory, planning, visual scanning ability.
immediately pre and immediately post-exercise
Trail Making Test
Time Frame: immediately pre and immediately post-exercise
The Trail Making Test was used to assess executive functions such as working memory, complex attention, planning and set switching, visual-spatial processing and motor abilities. The Trail Making Test consists of two parts, A and B.
immediately pre and immediately post-exercise
Y-Balance Test
Time Frame: immediately pre and immediately post-exercise
Y-Balance Test was used to evaluate dynamic balance, neuromuscular control and movement asymmetries.
immediately pre and immediately post-exercise
One Leg Standing Test
Time Frame: immediately pre and immediately post-exercise
One-leg Standing Test was used to assess static balance.
immediately pre and immediately post-exercise

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
International Physical Activity Questionnaire (IPAQ) Short Form
Time Frame: pre-assessments
The IPAQ Short Form was used to determine the physical activity levels of the participants.
pre-assessments
The Visual Analog Scale (VAS)
Time Frame: immediately pre and immediately post-exercise
This scale scores from 0 to 10. Higher scores indicate worse pain.
immediately pre and immediately post-exercise
Borg Fatigue Scale
Time Frame: immediately pre-exercises, during exercise and immediately post-exercise
It was used to determine the level of fatigue perceived by individuals before, during and after completing walking exercises.
immediately pre-exercises, during exercise and immediately post-exercise
Oxygen Saturation
Time Frame: immediately pre-exercises, during exercise and immediately post-exercise
In the study, saturation values were measured by pulse oximetry before, during and after exercise by the same physiotherapist.
immediately pre-exercises, during exercise and immediately post-exercise
Blood Pressure Assessment
Time Frame: immediately pre and immediately post-exercise
Blood pressure assessment was performed with a syphinguometer.
immediately pre and immediately post-exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Atlas University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 7, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 15, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 17, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 17, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 19, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 20, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 19, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • edaserenkarakaya

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings